Up next

Autoplay

The EPOCH-R clinical trial in Burkitt lymphoma

2 Views • 07/11/23
Share
Embed
administrator
administrator
Subscribers
0

Jeremy Abramson, MD, from the Massachusetts General Hospital, Massachusetts, MA gives an overview of the preliminary data being presented at the American Society of Hematology (ASH) 2015 Annual Meeting in Orlando, FL, on the results of the multi-center prospective Phase II study of Dose-Adjusted EPOCH-R for Burkitt Lymphoma.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay